What an at‑home s

IgE test measures—and how it fits into allergy diagnosis Specific IgE (sIgE) blood tests quantify allergen‑specific antibodies to help confirm sensitization to environmental triggers (pollen, pet dander, dust mites, molds). Unlike skin tests, sIgE is measured in a laboratory from a blood specimen and is not suppressed by antihistamines. Results must always be interpreted alongside clinical history because sensitization ≠ clinical allergy. See background on sIgE blood testing and when it’s used in place of skin testing. MedlinePlus, AAAAI overview.

Step‑by‑step timeline from order to doctor‑reviewed results

Wyndly’s process combines a CLIA‑certified lab workflow with physician review.

• Order & kit preparation: medical processing can take up to 3 business days.

• Outbound shipping to you: typically 2–4 days.

• Collect at home: a single finger‑prick onto a dried blood spot (DBS) card; follow the collection guide and mail back promptly.

• Lab processing after receipt: up to 6 business days (varies with accessioning time, batching, and test volume).

• Physician review and release: typically within a few hours and always within 2 business days.

• Some Wyndly partner kits advertise doctor‑reviewed results in ~2 business days after the lab completes testing.

Typical vs. worst‑case timing

Step	Typical	Worst‑case (rare)
Order processing	Same‑day to 1–3 business days	3 business days
Kit to your door	2–4 days	5–7 days
You collect & mail back	Same day	1–3 days
Lab processing after receipt	1–3 business days	Up to 6 business days
Doctor review	Hours to ≤2 business days	2 business days

What “CLIA‑certified” means for accuracy and reliability

U.S. clinical laboratories must meet federal quality standards under the Clinical Laboratory Improvement Amendments (CLIA) for analytical validity (accuracy, precision), quality systems, proficiency testing, and personnel qualifications. CLIA is administered by CMS in partnership with CDC.

Analytical accuracy: what s

IgE can and cannot tell you

• sIgE assays (e.g., ImmunoCAP) provide quantitative results (kU/L). Presence of sIgE indicates sensitization; it does not by itself prove clinical reactivity. Correlation with symptoms is strongest for pollens, house‑dust mite, some animal danders; weaker for certain foods and molds.

• Antihistamines do not suppress sIgE blood results (they do suppress skin tests), so you generally do not need to stop them for a blood test.

• Component or molecular testing and/or oral challenges may be needed if results are borderline or discordant with history (your physician will advise).

Pre‑analytical factors that most affect an at‑home (DBS) result

These influence whether the lab can produce a high‑quality, reportable measurement:

• Collection quality: fully fill and saturate each target circle; avoid smearing or touching; allow adequate air‑drying before packaging; use the desiccant; mail the same day.

• Transit time and temperature: IgE on DBS cards is stable when handled properly, but heat and prolonged delays can degrade signal. Follow kit instructions and ship promptly. (Studies demonstrate feasibility of measuring allergen‑specific antibodies from paper‑dried samples.)

• Insufficient sample/hemolysis: inadequate volume or contamination can require recollection; your care team will notify you if a redraw is needed.

• Panel scope: some extended analytes or component tests may require a larger sample than a single DBS can provide.

Interpretation factors (beyond the assay itself)

• Timing of exposure: sIgE reflects sensitization, not momentary exposure; recent exposure is not required to detect sensitization.

• Total IgE and threshold effects: very low results (e.g., near the 0.35 kU/L cut‑off) may be indeterminate; clinical context and, at times, repeat or orthogonal testing helps resolve uncertainty.

• Medications: antihistamines do not affect sIgE; discuss systemic immunosuppressants or biologics with your physician if applicable.

When to prefer a venous draw instead of a finger‑prick DBS

Choose a standard venipuncture (serum) collection when any of the following apply:

• You previously had an “insufficient sample” or non‑reportable result on DBS and need rapid resolution.

• Your clinician orders a broad or component‑resolved panel that exceeds DBS volume capacity.

• There is a strong clinical suspicion but initial DBS results are negative/low and confirmation is needed with an orthogonal method.

• You have conditions that make finger‑stick collection difficult (significant peripheral circulation issues, certain bleeding disorders) or you simply prefer a single phlebotomy tube. (These are practical collection considerations; your ordering physician will determine the appropriate specimen type.)

Practical tips to maximize accuracy on your first try

• Read the illustrated guide before you open anything. Lay out the supplies.

• Warm your hands and stand; gravity helps. Fill circles completely and let them air‑dry the recommended time.

• Use the prepaid mailer the same day. Track delivery in your Wyndly portal.

• Keep antihistamines if you rely on them—blood sIgE is unaffected.

How Wyndly differs (turnaround, oversight, support)

• CLIA‑certified lab partners and board‑certified physicians interpret every result.

• Doctor review is typically within hours and always within two business days once the lab posts results.

• Clear logistics and status tracking from order to therapy.

• If you already have results from the last 5 years, our doctors can review them and start treatment when appropriate.

FAQs

• Do I need to stop antihistamines before an at‑home sIgE blood test? No—antihistamines affect skin tests, not blood sIgE.

• How fast will I see results? Doctor‑reviewed results are typically released within hours to 2 business days after the lab posts your test; total door‑to‑door time depends on shipping and lab processing (see table).

• Are at‑home (DBS) antibody measurements reliable? Yes—when collected and shipped correctly; DBS approaches have shown reliable recovery of allergen‑specific antibodies, and your sample is analyzed in a CLIA‑certified lab.

• Can a single number predict reaction severity? No. sIgE quantifies sensitization and can estimate likelihood, but severity prediction requires clinical judgment and, in some cases, supervised challenges.

• When should I choose a venous draw? If you need a large/component panel, had an insufficient DBS, or your clinician wants orthogonal confirmation. (Your physician will specify the specimen type.)

---

References and further reading

• Wyndly logistics and timelines: Tracking • How to test • Existing test review • Partner kit turnaround

• Clinical context for sIgE testing: MedlinePlus • AAAAI—Allergy testing overview • Comparative data and guidance on interpretation: Study comparing ImmunoCAP and skin tests, Policy summary quoting AAAAI/ACAAI

• DBS antibody recovery research: Microarray from paper‑dried samples

• Quality framework: CDC CLIA